Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 12,900 shares, a growth of 1,742.9% from the October 15th total of 700 shares. Based on an average daily trading volume, of 88,800 shares, the short-interest ratio is presently 0.1 days.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group began coverage on Merck KGaA in a research report on Thursday, September 19th. They issued a “buy” rating on the stock.
View Our Latest Report on MKKGY
Merck KGaA Price Performance
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- What Are Dividend Champions? How to Invest in the Champions
- Rocket Lab is the Right Stock for the Right Time
- Investing in Travel Stocks Benefits
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- CD Calculator: Certificate of Deposit Calculator
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.